Pnc Financial Services Group, Inc. Exact Sciences Corp Transaction History

Pnc Financial Services Group, Inc.

  • $148 Billion
  • Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 11,284 shares of EXAS stock, worth $514,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,284
Previous 11,353 0.61%
Holding current value
$514,550
Previous $773,000 17.98%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$49.33 - $71.97 $3,403 - $4,965
-69 Reduced 0.61%
11,284 $634,000
Q3 2024

Nov 08, 2024
SELL
$42.43 - $70.83 $23,845 - $39,806
-562 Reduced 4.72%
11,353 $773,000
Q2 2024

Aug 09, 2024
SELL
$41.33 - $74.26 $168,254 - $302,312
-4,071 Reduced 25.47%
11,915 $503,000
Q1 2024

May 10, 2024
SELL
$56.27 - $73.77 $124,075 - $162,662
-2,205 Reduced 12.12%
15,986 $1.1 Million
Q4 2023

Feb 09, 2024
BUY
$59.06 - $75.72 $251,477 - $322,415
4,258 Added 30.56%
18,191 $1.35 Million
Q3 2023

Nov 13, 2023
SELL
$65.94 - $99.04 $162,608 - $244,232
-2,466 Reduced 15.04%
13,933 $950,000
Q2 2023

Aug 11, 2023
SELL
$62.68 - $95.05 $112,761 - $170,994
-1,799 Reduced 9.89%
16,399 $1.54 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $55,401 - $83,083
1,174 Added 6.9%
18,198 $1.23 Million
Q4 2022

Feb 10, 2023
SELL
$30.35 - $53.15 $124,617 - $218,233
-4,106 Reduced 19.43%
17,024 $842,000
Q3 2022

Nov 10, 2022
BUY
$31.97 - $49.37 $36,477 - $56,331
1,141 Added 5.71%
21,130 $686,000
Q2 2022

Aug 12, 2022
BUY
$35.61 - $76.23 $143,828 - $307,892
4,039 Added 25.32%
19,989 $787,000
Q1 2022

May 12, 2022
BUY
$57.56 - $82.54 $8,979 - $12,876
156 Added 0.99%
15,950 $1.12 Million
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $317,115 - $440,374
4,374 Added 38.3%
15,794 $1.23 Million
Q3 2021

Nov 05, 2021
BUY
$90.24 - $124.05 $12,092 - $16,622
134 Added 1.19%
11,420 $1.09 Million
Q2 2021

Aug 06, 2021
SELL
$93.66 - $139.27 $30,720 - $45,680
-328 Reduced 2.82%
11,286 $1.4 Million
Q1 2021

May 07, 2021
BUY
$116.57 - $155.01 $916,589 - $1.22 Million
7,863 Added 209.62%
11,614 $1.53 Million
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $31,078 - $44,341
312 Added 9.07%
3,751 $496,000
Q3 2020

Nov 06, 2020
SELL
$72.92 - $102.01 $12,323 - $17,239
-169 Reduced 4.68%
3,439 $350,000
Q2 2020

Aug 07, 2020
BUY
$55.75 - $92.75 $8,975 - $14,932
161 Added 4.67%
3,608 $313,000
Q1 2020

May 08, 2020
BUY
$37.9 - $104.44 $16,941 - $46,684
447 Added 14.9%
3,447 $199,000
Q4 2019

Feb 07, 2020
SELL
$77.66 - $99.74 $4,271 - $5,485
-55 Reduced 1.8%
3,000 $277,000
Q3 2019

Nov 08, 2019
BUY
$90.37 - $122.49 $78,802 - $106,811
872 Added 39.95%
3,055 $276,000
Q2 2019

Aug 09, 2019
SELL
$89.51 - $118.04 $24,615 - $32,461
-275 Reduced 11.19%
2,183 $0
Q1 2019

May 10, 2019
SELL
$61.98 - $96.5 $14,813 - $23,063
-239 Reduced 8.86%
2,458 $0
Q4 2018

Feb 08, 2019
SELL
$56.04 - $82.66 $658,806 - $971,750
-11,756 Reduced 81.34%
2,697 $170,000
Q3 2018

Nov 09, 2018
SELL
$48.29 - $80.6 $832,278 - $1.39 Million
-17,235 Reduced 54.39%
14,453 $0
Q2 2018

Aug 10, 2018
SELL
$37.84 - $69.96 $308,887 - $571,083
-8,163 Reduced 20.48%
31,688 $0
Q1 2018

May 11, 2018
SELL
$39.82 - $57.53 $87,484 - $126,393
-2,197 Reduced 5.22%
39,851 $0
Q4 2017

Feb 09, 2018
BUY
$46.49 - $60.51 $639,051 - $831,770
13,746 Added 48.57%
42,048 $0
Q3 2017

Nov 13, 2017
BUY
$37.05 - $47.12 $1.05 Million - $1.33 Million
28,302
28,302 $0

Others Institutions Holding EXAS

# of Institutions
668
Shares Held
152M
Call Options Held
4.25M
Put Options Held
1.89M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.07B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email